A detailed history of Zevenbergen Capital Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Zevenbergen Capital Investments LLC holds 21,484 shares of ABT stock, worth $2.44 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,484
Previous 22,834 5.91%
Holding current value
$2.44 Million
Previous $2.37 Million 3.25%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $135,094 - $159,475
-1,350 Reduced 5.91%
21,484 $2.45 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $112,313 - $125,370
-1,115 Reduced 4.66%
22,834 $2.37 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $20,261 - $22,377
-185 Reduced 0.77%
23,949 $2.72 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $244,865 - $299,736
2,715 Added 12.68%
24,134 $2.66 Million
Q3 2023

Nov 01, 2023

BUY
$95.53 - $114.62 $12,418 - $14,900
130 Added 0.61%
21,419 $2.07 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $13,101 - $14,597
130 Added 0.61%
21,289 $2.32 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $6,295 - $7,410
65 Added 0.31%
21,159 $2.14 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $188,218 - $220,809
-1,980 Reduced 8.58%
21,094 $2.32 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $74,892 - $86,711
774 Added 3.47%
23,074 $2.23 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $83,697 - $101,163
820 Added 3.82%
22,300 $2.42 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $31,355 - $38,236
275 Added 1.3%
21,480 $2.54 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $315,396 - $386,185
2,730 Added 14.78%
21,205 $2.98 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $10,032 - $11,099
86 Added 0.47%
18,475 $2.18 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $95,739 - $112,699
905 Added 5.18%
18,389 $2.13 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $261,216 - $307,752
2,400 Added 15.91%
17,484 $2.1 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $298,200 - $324,952
2,840 Added 23.2%
15,084 $1.65 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $6,873 - $8,346
-75 Reduced 0.61%
12,244 $1.33 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $19,908 - $25,480
260 Added 2.16%
12,319 $1.13 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $83,236 - $121,714
1,325 Added 12.34%
12,059 $952,000
Q4 2019

Feb 07, 2020

BUY
$78.51 - $87.4 $15,702 - $17,480
200 Added 1.9%
10,734 $932,000
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $25,943 - $28,130
317 Added 3.1%
10,534 $881,000
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $41,906 - $48,875
575 Added 5.96%
10,217 $859,000
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $331 - $400
-5 Reduced 0.05%
9,642 $771,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $19,340 - $21,909
295 Added 3.15%
9,647 $698,000
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $12,162 - $14,672
200 Added 2.19%
9,352 $686,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $50,949 - $56,232
885 Added 10.71%
9,152 $558,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $465,184 - $525,946
8,267 New
8,267 $495,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Zevenbergen Capital Investments LLC Portfolio

Follow Zevenbergen Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.